Zhao Hui Zhang
Founder presso WUXI PHARMATECH (CAYMAN) INC. (ADR)
Patrimonio netto: - $ in data 31/03/2024
Profilo
Zhao Hui Zhang is the founder of Wuxi PharmaTech (Cayman), Inc. (founded in 2000) and WuXi AppTec Co., Ltd.
(founded in 2000).
At Wuxi PharmaTech (Cayman), Inc., Mr. Zhang holds the title of Director & Senior Vice President-Operations.
At WuXi AppTec Co., Ltd., Mr. Zhang holds the title of Executive Director & Vice President.
Mr. Zhang's current job(s) include being the Chief Executive Officer at Wuxi Qingye Investment Consultancy Ltd.
since 2000 and being a Director at Shanghai Syn-the-all Pharmaceutical Co. Ltd.
since 2017.
Mr. Zhang's former job(s) include being a Director-Supervisory Board at China National Medicines Co., Ltd.
from 2009 to 2012, being a Director at Wuxi Biologics (Cayman), Inc., and being a Vice President at American Silver Bell Co.Mr. Zhang's education history includes an MBA from China Europe International Business School and an undergraduate degree from Jiangnan University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Zhao Hui Zhang
Società | Posizione | Inizio |
---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Founder | 01/01/2000 |
WUXI APPTEC CO., LTD. | Founder | 01/12/2000 |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Director/Board Member | 02/11/2017 |
Wuxi Qingye Investment Consultancy Ltd. | Chief Executive Officer | 01/01/2000 |
Precedenti posizioni note di Zhao Hui Zhang
Società | Posizione | Fine |
---|---|---|
CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | - |
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | - |
American Silver Bell Co. | Corporate Officer/Principal | - |
Formazione di Zhao Hui Zhang
China Europe International Business School | Masters Business Admin |
Jiangnan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
Aziende private | 4 |
---|---|
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
American Silver Bell Co. | |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Health Technology |
Wuxi Qingye Investment Consultancy Ltd. |
- Borsa valori
- Insiders
- Zhao Hui Zhang